| Application no. and date | 21217553.3 (espacenet) (Federated) (European Patent Register), 20180816 | | Patent/reg. no. and date | DK/EP 4046994, 20240221 | | Publication date | 20220824 | | Priority no. and date | US 201762546974 P, 20170817 | | EP pub. no. and date |
EP 4046994 20220824 | | Effective date | | | Applicant/owner | Gilead Sciences, Inc., 333 Lakeside Drive
Foster City, CA 94404, US | | Applicant ref. no. | | | Inventor | SHI, Bing,
Foster City, 94404, US,
HOUSTON, Travis, Lee,
Albany, 12203, US | | Representative | | | Opponent | | | IPC Class | A61K 31/454 (2006.01) , A61P 31/18 (2006.01) , C07D 401/14 (2006.01) | | Title | CHOLINE SALT FORMS OF AN HIV CAPSID INHIBITOR | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
